|
⚲
|
| Keyboard |
| Makower Joshua
✚
|
|
|---|---|
| CIK # | 0001235952 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001235952] | |
| 4 | [0001235952] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eargo Inc EAR
Stock Options (Right to Buy) · derivative
|
2022-10-12 | Grant | 74,074 | $0.00 | |
|
Eargo Inc EAR
Stock Options (Right to Buy) · derivative
|
2022-08-23 | Grant | 74,805 | $0.00 | |
|
NeueHealth Inc BHG
Series E Preferred · derivative
|
2021-06-28 | Conversion | 2,448,856 | $0.00 | |
|
NeueHealth Inc BHG
Series C Preferred · derivative
|
2021-06-28 | Conversion | 1,954,906 | $0.00 | |
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 14,942,061 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 7,346,568 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Buy | 1,694,444 | $18.00 | 30,499,992 |
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 10,601,925 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 26,703,498 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 19,549,068 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 3,327,852 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 3,494,244 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 5,864,718 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 38,137,197 | ||
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2021-06-28 | Conversion | 669,002 | ||
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2021-06-28 | Conversion | 3,257,328 | ||
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2021-06-28 | Buy | 1,050,000 | $19.00 | 19,950,000 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2021-06-28 | Conversion | 2,715,968 | ||
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Buy | 250,000 | $18.00 | 4,500,000 |
|
NeueHealth Inc BHG
Common Stock
|
2021-06-28 | Conversion | 3,673,284 | ||
| showing 20 of 144 most recent transactions | |||||